Demeter Closes ￥10M Series A Financing from Fortune Venture Capital

(VCBeat) Apr. 19, 2021 -- Hunan Demeter Instrument Co., Ltd. ("Demeter"), which specializes in the clinical research of mass spectrometry and chromatography, today announced it has received tens of millions of yuan in Series A financing from Fortune Venture Capital by directly investing in Changsha Anax Instrument Co., Ltd. ("Anax"), Demeter's parent company. The funds raised will be used for technology R&D, product manufacturing, talent recruitment and marketing of Demeter’s clinical mass spectrometry products.

Through independent innovation, Demeter has broken through the core technical barriers of clinical application in the field of mass spectrometry and changed the characteristics of chromatography and mass spectrometry in applications.

Demeter has competitiveness in patent layout, product manufacturing and compliance, technology research, and market performance. At present, the company's products have implemented in 32 provinces and cities in China, entering into hundreds of first-class hospitals, with total sales of more than 100 million.

Demeter's R&D team is engaged in the development of cutting-edge clinical chromatography/mass spectrometry technology for 20 years and has made breakthroughs in the automated chromatography and stabilization technology in mass spectrometry. Demeter has launched the pioneering MS-MATE high-stable clinical mass spectrometry system, as well as the MLC/FLC automatic two-dimensional liquid chromatography system for clinical testings. By realizing the first research, first production, and first registration of chromatography-mass spectrometry products, Demeter not only creates a new technical system for mass spectrometry but also becomes a representative enterprise with strong power in the industry.

Founded in April 2000, Fortune Capital is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focuses its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.

Fortune Capital is ranked among the highest performing VC/PE firms in China. In addition to providing capital, Fortune Capital provides its investee companies with personalized value-added services.